Min-Xin Fu
- Clinical Biochemistry top 0.1%
- Advanced Glycation End Products research 10
- Paraoxonase enzyme and polymorphisms 1
-
- Natural Antidiabetic Agents Studies 3
- Diabetes, Cardiovascular Risks, and Lipoproteins 1
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities 2
- Antioxidant Activity and Oxidative Stress 2
- Aging top 10%
- Nephrology top 5%
-
- Biochemical effects in animals 3
-
- Aldose Reductase and Taurine 1
- Co-authors
- Suzanne R. ThorpeJohn BaynesTimothy J. LyonsAlicia J. JenkinsJesús R. RequenaJames A. BlackledgeKevin J. Wells‐KnechtS R Thorpe
- Journals
- Diabetes (3 papers)The Journals of Gerontology Series A (1 paper)Current Eye Research (1 paper)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Min-Xin Fu
12 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Clinical Biochemistry 1.3k
- Endocrinology, Diabetes and Metabolism 746
- Biochemistry 215
- Aging 36
- Nephrology 137
Countries citing papers authored by Min-Xin Fu
This map shows the geographic impact of Min-Xin Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min-Xin Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min-Xin Fu more than expected).
Fields of papers citing papers by Min-Xin Fu
This network shows the impact of papers produced by Min-Xin Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min-Xin Fu. The network helps show where Min-Xin Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min-Xin Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 17 | |
| 2 | 2000 | 236 | |
| 3 | 1999 | 12 | |
| 4 | 1999 | 31 | |
| 5 | 1998 | 128 | |
| 6 | 1998 | 62 | |
| 7 | 1996 | 213 | |
| 8 | The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactionsbreakdown → | 1996 | 686 |
| 9 | 1995 | 100 | |
| 10 | 1994 | 396 | |
| 11 | 1994 | 106 | |
| 12 | 1992 | 127 |
About Min-Xin Fu
Min-Xin Fu is a scholar working on Clinical Biochemistry, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 2.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (10 papers), Biochemical effects in animals (3 papers), Natural Antidiabetic Agents Studies (3 papers), Phytochemicals and Antioxidant Activities (2 papers), Antioxidant Activity and Oxidative Stress (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Aldose Reductase and Taurine (1 paper) and Paraoxonase enzyme and polymorphisms (1 paper). The work is most often cited by research in Clinical Biochemistry (1.3k citations), Endocrinology, Diabetes and Metabolism (746 citations) and Biochemistry (215 citations). Min-Xin Fu has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Suzanne R. Thorpe, John Baynes, Timothy J. Lyons, Alicia J. Jenkins, Jesús R. Requena, James A. Blackledge, Kevin J. Wells‐Knecht, S R Thorpe, Mushtaq Ahmed and Anne L. Peters. Their work appears in journals such as Diabetes, The Journals of Gerontology Series A, Current Eye Research, Kidney International and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.